"Major Banks" CMB International's Investment Ratings and Target Prices for Pharmaceutical Stocks (Table)

China Merchants Jinling International published a research report, listing the investment ratings and target prices for pharmaceutical stocks as follows:

Stock | Investment Rating | Target Price

AstraZeneca (AZN.US) | Buy | $93.3

Beigene (06160.HK) | Buy | HKD 208.8

Hansoh Pharmaceutical (03692.HK) | Buy | HKD 33

Innovent Biologics (01801.HK) | Buy | HKD 84

SINO BIOPHARM (01177.HK) | Buy | HKD 5.9

Kintor Pharmaceutical-B (06990.HK) | Buy | HKD 400

Legend Biotech (LEGN.US) | Buy | $65

WuXi AppTec (02268.HK) | Buy | HKD 51

Hutchison China MediTech (00013.HK) | Buy | HKD 44

Sihuan Pharmaceutical (02096.HK) | Buy | HKD 14.3

THDB (600867.SH) | Buy | RMB 14

Genscript Biotech (01952.HK) | Buy | HKD 65

CanSino Biologics-B (02162.HK) | Buy | HKD 57

Jinxin Fertility (01951.HK) | Buy | HKD 3.75

Guangzhou Pharmaceutical (02273.HK) | Buy | HKD 42

Hengrui Medicine (600276.SH) | Neutral | RMB 51

Shijiazhuang Pharmaceutical Group (01093.HK) | Neutral | HKD 7.2

Kangmei Pharmaceutical (002422.SZ) | Neutral | RMB 40.2

Bristol-Myers Squibb (BMY.US) | Sell | $33.1